LPL Financial
CLGN icon

LPL Financial’s CollPlant Biotechnologies CLGN Stock Holding History

LPL Financial’s Portfolio CLGN Stock Details CLGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-28,070
Closed -$191K – 4468
2022
Q3 		$191K Sell
28,070
-17,000
-38% -$138K ﹤0.01% 3957
2022
Q2 		$361K Buy
+45,070
New +$414K ﹤0.01% 3470
2022
Q1 		– Sell
-14,770
Closed -$242K – 4215
2021
Q4 		$242K Buy
+14,770
New +$264K ﹤0.01% 3851

Other funds holding CLGN

RAM
Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return
IMOV
Investment Management of Virginia Richmond, Virginia $526M AUM 3.23% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
BFEC
Benjamin F. Edwards & Company St. Louis, Missouri $5.69B AUM 15.37% 1-Year Est. Return
Zurich Cantonal Bank
Zurich Cantonal Bank Zurich, Switzerland $46B AUM 27.59% 1-Year Est. Return
SQA
Simon Quick Advisors Morristown, New Jersey $2.19B AUM 17.29% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

LPL Financial's CLGN Position: Q4 2022 in Review

LPL Financial sold out of CollPlant Biotechnologies (CLGN) in Q4 2022, closing a stake of 28,070 shares — an estimated $191K sold.

LPL Financial first reported a position in CLGN in Q4 2021 and held it in 3 quarters. The position peaked at $361K in Q2 2022. 18 funds tracked by Wall St. Rank hold CLGN as of Q4 2022.

  • LPL Financial reported no remaining CollPlant Biotechnologies position as of Q4 2022 after selling out during the quarter.
  • LPL Financial sold 28,070 CollPlant Biotechnologies shares in Q4 2022, an estimated $191K.
  • LPL Financial first reported a position in CollPlant Biotechnologies in Q4 2021 and held it in 3 quarters.
  • LPL Financial's CollPlant Biotechnologies position peaked at $361K in Q2 2022.
  • 18 funds tracked by Wall St. Rank held CollPlant Biotechnologies as of Q4 2022.

Based on LPL Financial's 13F filing for Q4 2022, filed 7 Feb 2023.